RIPK1 and cancer: However, necrosis has been shown to promote tumorigenesis and metastasis by inducing an inflammatory response, as Liu et al.21reported that it has been reported that silencing RIPK1 and RIPK3 in cancer cells decreases the pathogenic capacity of cancer cell lines and increases their sensitivity to chemotherapy.